FDA: Leiner should have recalled drugs

Over-the-counter drug maker Leiner Health Products is under the FDA gun. Regulators say the company falsified quality-control test results and failed to recall drugs it should have taken off the market. Leiner officials blamed the problems on rogue employees who've since been terminated.

The FDA swept into Leiner's South Carolina plan in January on the strength of employee complaints. The agency is still trying to determine whether the company committed criminal violations, according to an affidavit filed in a nearby federal court.

- check out this article from the Charlotte Observer

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.